China NMPA Drug Inspection - Jiangsu Yaodu Zhangshu Pharmaceutical Co., Ltd. - Zhi Bai Di Huang Wan (Concentrated Pill)
China NMPA drug inspection for Jiangsu Yaodu Zhangshu Pharmaceutical Co., Ltd. published August 17, 2018. Drug: Zhi Bai Di Huang Wan (Concentrated Pill). The Ningxia Food and Drug Administration, operating under the "Drug Administration Law of the People's Republic of China
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jiangsu Yaodu Zhangshu Pharmaceutical Co., Ltd. published August 17, 2018. Drug: Zhi Bai Di Huang Wan (Concentrated Pill). The Ningxia Food and Drug Administration, operating under the "Drug Administration Law of the People's Republic of China
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox